Overview
While structural racism and social determinants of health (SDOH) are recognized as contributors to inequities in cancer care and outcomes, there remains limited understanding of their specific impact on care inequities among patients with endometrial cancer. Notably, Black women with endometrial cancer face nearly double the risk of death compared to their White counterparts. In this study, researchers aimed to investigate how structural racism and SDOH contribute to racial/ethnic inequities in care for patients with advanced endometrial cancer (aEC).
Why this matters
This research carries significant weight as it illuminates racial/ethnic inequities observed across various facets of care for patients with aEC, encompassing treatment initiation, biomarker testing, and clinical trial participation. Notably, structural racism and SDOH were identified as substantial contributors to inequities in clinical trial participation. These findings emphasize the importance of initiatives promoting diversity in endometrial cancer trials and rectifying overall inequities in endometrial cancer outcomes. Prioritizing endeavors to alleviate the structural and social barriers to clinical trial participation is critical to achieving greater equity in endometrial cancer care and outcomes.